• 1. Department of neurology, Shanxi Provincial Peoples, Hospital, Taiyuan 030012, China;
  • 2. Department of Neurology, General Hospital of Taiyuan Iron & Steel CO., LTD. (TISCO), Taiyuan 030003, China;
YANG Jianzhong, Email: 1595021181@qq.com
Export PDF Favorites Scan Get Citation

Objective To study the differentially expressed proteins of recombinant human erythropoietin (r-HuEPO) in hippocampus of Pentetrazol (PTZ) -induced epileptic rats, and to provide a basis for exploring the pathogenesis of epilepsy and seeking new therapeutic targets. Methods  Twelve 6~8-week-old Sprague Dawley rats that weighted 230~250 g were randomly divided into two groups: PTZ group, PTZ+ EPO group. The differential proteins of recombinant human EPO in hippocampus of pentylenetetrazole-induced epileptic rats were analyzed and identified by TMT technique based on mass spectrometry.Results  139 differentially expressed protein sites were detected in hippocampal tissues of epileptic rats, of which 55 were up-regulated and 84 down-regulated. Conclusion  Recombinant human erythropoietin can inhibit many differentially expressed proteins in the hippocampus of pentaerythraze-induced eclampsia rats by upregulation of Isocitrate dehydrogenase (NADP), Reduced nicotinamide purine dinucleotide phosphate (NADPH), Thioredoxin reductase 2 mitochondrial (TrxR), reduce nerve cell damage.

Citation: ZHANG Wenjuan, WANG Guangwen, YANG Jianzhong. Study of recombinant human erythropoietin on hippocampal proteomics in pentylenetetrazole-induced epileptic rats. Journal of Epilepsy, 2022, 8(6): 529-534. doi: 10.7507/2096-0247.202207006 Copy

  • Previous Article

    Preliminary analysis of epilepsy patients’ EEG big data based on CAAE new EEG reporting system
  • Next Article

    拉考沙胺在成人及儿童不同类型癫痫中的研究进展